Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Laninamivir> ?p ?o. }
Showing items 1 to 64 of
64
with 100 items per page.
- Laninamivir abstract "Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials. It is a long-acting neuraminidase inhibitor administered by nasal inhalation.Laninamivir was approved for influenza treatment in Japan in 2010 and for prophylaxis in 2013. It is currently marketed under the name "Inavir" by Daiichi Sankyo. Biota Pharmaceuticals and Daiichi Sankyo co-own Laninamivir. On 1 April 2011, BARDA awarded up to an estimated U$231m to Biota Pharmaceuticals (Formerly Biota Holdings Ltd) wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of Laninamivir in the US. It is under clinical evaluations in other countries.".
- Laninamivir atcPrefix "none".
- Laninamivir casNumber "203120-17-6".
- Laninamivir fdaUniiCode "B408IW3GL5".
- Laninamivir iupacName "(4S,5R,6R)-5-acetamido-4-carbamimidamido-6-[(1R,2R)-3-hydroxy-2-methoxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid".
- Laninamivir pubchem "502272".
- Laninamivir thumbnail Laninamivir.svg?width=300.
- Laninamivir wikiPageID "23927032".
- Laninamivir wikiPageRevisionID "605851953".
- Laninamivir atcPrefix "none".
- Laninamivir c "13".
- Laninamivir casNumber "203120".
- Laninamivir chembl "466246".
- Laninamivir chemspiderid "439182".
- Laninamivir h "22".
- Laninamivir hasPhotoCollection Laninamivir.
- Laninamivir inchi "1".
- Laninamivir inchikey "QNRRHYPPQFELSF-CNYIRLTGBV".
- Laninamivir iupacName "-5".
- Laninamivir molecularWeight "346.33638".
- Laninamivir n "4".
- Laninamivir o "7".
- Laninamivir pubchem "502272".
- Laninamivir routesOfAdministration "Inhalation".
- Laninamivir smiles "O=CC=1O[C@@H][C@H][C@@H]C=1".
- Laninamivir stdinchi "1".
- Laninamivir stdinchikey "QNRRHYPPQFELSF-CNYIRLTGSA-N".
- Laninamivir unii "B408IW3GL5".
- Laninamivir verifiedfields "changed".
- Laninamivir verifiedrevid "462088695".
- Laninamivir width "200".
- Laninamivir subject Category:Acetamides.
- Laninamivir subject Category:Dihydropyrans.
- Laninamivir subject Category:Guanidines.
- Laninamivir subject Category:Neuraminidase_inhibitors.
- Laninamivir type Abstraction100002137.
- Laninamivir type Acetamide114711197.
- Laninamivir type Acetamides.
- Laninamivir type Amide114724264.
- Laninamivir type Chemical114806838.
- Laninamivir type Compound114818238.
- Laninamivir type Material114580897.
- Laninamivir type Matter100020827.
- Laninamivir type OrganicCompound114727670.
- Laninamivir type Part113809207.
- Laninamivir type PhysicalEntity100001930.
- Laninamivir type Relation100031921.
- Laninamivir type Substance100019613.
- Laninamivir type Drug.
- Laninamivir type DrugProduct.
- Laninamivir type FunctionalSubstance.
- Laninamivir comment "Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials. It is a long-acting neuraminidase inhibitor administered by nasal inhalation.Laninamivir was approved for influenza treatment in Japan in 2010 and for prophylaxis in 2013. It is currently marketed under the name "Inavir" by Daiichi Sankyo.".
- Laninamivir label "Laninamivir".
- Laninamivir label "Laninamivir".
- Laninamivir label "ラニナミビル".
- Laninamivir sameAs Laninamivir.
- Laninamivir sameAs ラニナミビル.
- Laninamivir sameAs m.076yyn_.
- Laninamivir sameAs Q6487096.
- Laninamivir sameAs Q6487096.
- Laninamivir sameAs Laninamivir.
- Laninamivir wasDerivedFrom Laninamivir?oldid=605851953.
- Laninamivir depiction Laninamivir.svg.
- Laninamivir isPrimaryTopicOf Laninamivir.